Stage III Ovarian Epithelial Cancer Completed Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028510 (Stage III Ovarian Epithelial Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00059787Erlotinib Plus Carboplatin and Paclitaxel in Ovarian CarcinomaTreatment
NCT00466960Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous ChemotherapyTreatment